Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 3/20 | 1.00 |
| ▸ | FNTA | P49354 | 6/20 | 0.59 |
| ▸ | FNTB | P49356 | 6/20 | 0.59 |
| ▸ | AR | P10275 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.57 |
| ▸ | PGR | P06401 | 4/20 | 0.57 |
| ▸ | HRH1 | P35367 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anecortave Acetate SCHEMBL8470303 | 1.00 | NR3C1 (1.00) | NR3C1FNTAFNTBARKMT2A | |
| Anecortave Acetate SCHEMBL2118233 | 1.00 | NR3C1 (1.00) | NR3C1FNTAFNTBARKMT2A | |
| Anecortave Acetate SCHEMBL14612532 | 1.00 | NR3C1 (1.00) | NR3C1FNTAFNTBARKMT2A | |
| Anecortave Acetate SCHEMBL8472390 | 0.96 | NR3C1 (0.93) | NR3C1FNTAFNTBARKMT2A | |
| SCHEMBL25177986 | 0.92 | NR3C1 (0.85) | NR3C1FNTAFNTBARKMT2A | |
| SCHEMBL25184624 | 0.92 | NR3C1 (0.85) | NR3C1FNTAFNTBARKMT2A | |
| SCHEMBL23974865 | 0.92 | NR3C1 (0.84) | NR3C1FNTAFNTBARKMT2A | |
| SCHEMBL25181307 | 0.91 | NR3C1 (0.83) | NR3C1FNTAFNTBARKMT2A | |
| SCHEMBL3437593 | 0.91 | NR3C1 (0.83) | NR3C1FNTAFNTBARKMT2A | |
| SCHEMBL3437604 | 0.90 | NR3C1 (0.82) | NR3C1FNTAFNTBARKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8240 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260048096-A1 | METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS | STEALTH BIOTHERAPEUTICS INC. (US) | 2026-02-19 | — | — | US | claimed |
| EP-4596049-A2 | PEPTIDE FOR USE IN PREVENTING OR TREATING MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4302829-B1 | PEPTIDE FOR USE IN PREVENTING OR TREATING MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC (US) | 2025-05-21 | — | — | EP | claimed |
| US-12268779-B2 | Ophthalmic emulsion | ALCON INC. (CH) | 2025-04-08 | — | — | US | claimed |
| US-20250108001-A1 | TOPICAL OCULAR ADMINISTRATION OF AMBROXOL FOR OCULAR PAIN | NEUVISION DEVELOPMENT LLC | 2025-04-03 | — | — | US | claimed |
| US-20250090621-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | STEALTH BIOTHERAPEUTICS INC. (US) | 2025-03-20 | — | — | US | claimed |
| US-20250057962-A1 | PROCESSABLE COMPOSITIONS AND USE FOR THE SAME | RIPPLE THERAPEUTICS CORPORATION (CA) | 2025-02-20 | — | — | US | claimed |
| CN-118994021-B | Method for recovering imidazole from anecortave acetate byproduct imidazole hydrochloride | 山东同新药业有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119317415-A | Topical ocular administration of ambroxol for ocular pain | 纽视发展有限责任公司 | 2025-01-14 | — | — | CN | claimed |
| US-5679666-A | ADMINISTERING TOPICALLY, SYSTEMICALLY OR INTRAOCULARLY TO A HOST STEROIDS SELECTED FROM PREGNADIEN DERIVATIVES, HYDROXYPROGESTERONE AND TETRAHYDROCORTEXOLONE | ALCON LABORATORIES, INC. (US) | 1997-10-21 | — | — | US | claimed |
| US-5371078-A | Angiostatic steroids and methods and compositions for controlling ocular hypertension | ALCON LABORATORIES, INC. (US) | 1994-12-06 | — | — | US | claimed |
| EP-0614463-A1 | ANGIOSTATIC STEROIDS | ALCON LABORATORIES, INC. (US) | 1994-09-14 | — | — | EP | claimed |
| WO-1993010141-A2 | ANGIOSTATIC STEROIDS | ALCON LABORATORIES, INC. (US) | 1993-05-27 | — | — | WO | claimed |
| US-4749649-A | Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen | THE UPJOHN COMPANY (US) | 1988-06-07 | — | — | US | claimed |
| US-4684610-A | ARTHROBACTER OR BACTERIUM | THE UPJOHN COMPANY (US) | 1987-08-04 | — | — | US | claimed |
| EP-0127294-B1 | STEROID DEHYDROGENATION | THE UPJOHN COMPANY (US) | 1986-12-17 | — | — | EP | claimed |
| EP-0127294-A1 | Steroid dehydrogenation | THE UPJOHN COMPANY (US) | 1984-12-05 | — | — | EP | claimed |
| US-4154748-A | Phosphate catalyzed acylation of steroidal tertiary alcohols | THE UPJOHN COMPANY (US) | 1979-05-15 | — | — | US | claimed |
| US-4041055-A | SULFENYLATION, MICHAEL ADDITION, REACTION WITH THIOPHILE, HYDROLYSIS | THE UPJOHN COMPANY (US) | 1977-08-09 | — | — | US | claimed |